ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
icatibant accord
accord healthcare s.l.u. - icatibant acetate - ofsabjúgur, arfgengur - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
icatibant stada stungulyf, lausn í áfylltri sprautu 30 mg
stada arzneimittel ag - icatibantum inn - stungulyf, lausn í áfylltri sprautu - 30 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
firazyr
takeda pharmaceuticals international ag - icatibant - ofsabjúgur, arfgengur - hjarta meðferð - firazyr er ætlað til meðferðar við bráðri árás arfgengs ofsabjúgs (hae) hjá fullorðnum (með skort á c1-esterasa-hemlum).